Amanta Healthcare Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Amanta Healthcare

DeciZen not available for IPO

10 Year X-Ray of Amanta Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 9.8%10.6%12.7%10.3%8.4%8.3%8.9%40%13.4%14.2%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 175203211192185184171225259280185
Sales YoY Gr.-15.9%4.2%-9.3%-3.5%-0.3%-7.1%31.6%14.9%8.2%-
Adj EPS 0.13.46.33.9-7.1-7.5-8.22.1-1.21.5-5.3
YoY Gr.-4100%88.1%-38.6%-282.5%NANANA-156.6%NA-
BVPS (₹) 34.14046.32517.910.92.724.223.424.716
Adj Net
Profit
0.312.423.210.3-19-20-22.15.7-3.24-19
Cash Flow from Ops. 25.339.640.225.232.237.933.463.542.658.1-
Debt/CF from Ops. 3.72.42.210.17.76.173.55.13.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.4%8.7%17.9%8.2%
Adj EPS 38.4%NANANA
BVPS-3.5%6.7%108.9%5.4%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
0.26.911.47.3-33.1-52-121.415.7-5.16.2-26.1
Op. Profit
Mgn %
20.420.424.424.222.120.322.423.819.820.7NAN
Net Profit
Mgn %
0.26.1115.4-10.3-10.9-12.92.5-1.31.4-10.1
Debt to
Equity
0.60.50.43.85.27.932.33.43.43.1-
Working Cap
Days
1731801942382692772962151791620
Cash Conv.
Cycle
65655991114133160120103970

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Amanta Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) -5.3 -
TTM Sales (₹ Cr.) 185 -
BVPS (₹.) 16 -
Reserves (₹ Cr.) 21 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 35.4
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Amanta Healthcare:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Amanta Healthcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales174.91202.75211.17191.55184.87184.37171.29225.44259.13280.34
Operating Expenses 139.23161.43159.91145.19143.96147132.96171.81208.23222.85
Manufacturing Costs21.6720.8519.8721.4421.2023.3819.2272.5383.0383.88
Material Costs65.6984.6281.5168.4766.8963.8349.5240.3561.4770.13
Employee Cost 26.8728.3627.773031.3433.2934.4328.1331.8732.55
Other Costs 24.9927.6030.7525.2924.5226.5029.7830.8031.8636.30
Operating Profit 35.6841.3251.2646.3540.9137.3738.3453.6350.9057.49
Operating Profit Margin (%) 20.4%20.4%24.3%24.2%22.1%20.3%22.4%23.8%19.6%20.5%
Other Income 1.381.611.052.291.692.131.060.835.411.27
Interest 11.9013.9612.2919.8140.5538.1340.1343.9135.2733.64
Depreciation 12.4413.7514.6116.4416.5416.4917.0217.2818.3519.73
Exceptional Items 00-0.36000068.5200
Profit Before Tax 12.7115.2225.0612.39-14.49-15.12-17.7661.792.695.39
Tax 12.162.591.901.064.253.764.087.914.801.76
Profit After Tax 0.5512.6323.1611.33-18.75-18.87-21.8353.88-2.113.63
PAT Margin (%) 0.3%6.2%11.0%5.9%-10.1%-10.2%-12.7%23.9%-0.8%1.3%
Adjusted EPS (₹)0.23.46.34.3-7.0-7.0-8.120.1-0.81.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 168.64192.27215.4366.5247.9729.107.2664.9762.8866.29
Share Capital 81.3181.8681.8626.6326.8326.8326.8326.8326.8326.83
Reserves 87.33110.42133.5839.8921.142.27-19.5638.1436.0539.46
Minority Interest0000000000
Debt80.4286.1775.52242.93237.68226.65234.65217.71211.09192.14
Long Term Debt37.7742.2732.34200.36195.77192.44158.08175.91175.55149.03
Short Term Debt42.6643.8943.1842.5741.9234.2176.5641.8035.5443.12
Trade Payables2932.3734.7629.2821.9517.3825.303936.2124.80
Others Liabilities 60.3158.3863.8367.2595.07114.55124.9057.7864.0171.96
Total Liabilities 338.36369.19389.55405.98402.67387.67392.11379.46374.19355.20

Fixed Assets

Gross Block321.58346.97374.53395.66382.75395.42399.16259.35274.04279.04
Accumulated Depreciation86.96100.71112.61128.80135.90151.52157.3518.0236.3650.89
Net Fixed Assets234.62246.26261.92266.86246.85243.90241.81241.33237.68228.15
CWIP 2.510.090.781.980.2300000
Investments 0000.100.100.101.503.343.473.72
Inventories36.8130.3029.0133.8438.3739.3457.2471.1068.9259.45
Trade Receivables41.1751.7761.0454.0952.2352.2851.4844.8153.5848.17
Cash Equivalents 5.856.204.566.8113.106.228.879.683.874.10
Others Assets17.4034.5732.2342.3151.7845.8331.219.196.6711.62
Total Assets 338.36369.19389.55405.98402.67387.67392.11379.46374.19355.20

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 25.2739.5940.2025.1932.2237.8833.3963.5342.5858.07
PBT 12.7115.2225.0612.39-14.49-15.12-17.7661.792.695.39
Adjustment 25.0928.0227.0936.1456.4154.1558.56-6.8953.5353.66
Changes in Working Capital -9.68-0.31-7.36-16.98-3.08-0.99-12.588.73-7.334.97
Tax Paid -2.27-2.73-3.31-1.70-6.62-0.165.18-0.10-6.31-5.95
Cash Flow From Investing Activity -36.74-35.99-21.05-174.96-4.67-10.91-16.67-5.38-6.53-10.32
Capex -33.71-36.55-23.10-14.79-4.63-10.73-11.96-2.81-6.28-11.98
Net Investments 0000000-2.93-0.471.30
Others -3.030.552.06-160.17-0.04-0.18-4.700.360.220.36
Cash Flow From Financing Activity 11.31-3.18-19.64152.20-21.22-35.11-16.91-51.99-42.32-46.32
Net Proceeds from Shares 00.5500000000
Net Proceeds from Borrowing 0000000000
Interest Paid -12.36-14.65-12.45-11.56-15.21-19.33-21.05-41.29-29.02-26.26
Dividend Paid 0000000000
Others 23.6710.93-7.19163.76-6.01-15.774.14-10.70-13.30-20.07
Net Cash Flow -0.160.42-0.482.436.33-8.14-0.186.17-6.271.43
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)0.449.3314.599.57-32.75-48.98-120.09149.18-3.35.63
ROCE (%)9.8310.6312.6910.338.448.278.9139.9913.4314.19
Asset Turnover Ratio0.580.610.590.490.460.470.440.580.690.77
PAT to CFO Conversion(x)45.953.131.742.22N/AN/AN/A1.18N/A16
Working Capital Days
Receivable Days727992108105103111786966
Inventory Days6557485971771031049984
Payable Days151132150171140112157291223159

Amanta Healthcare Ltd Stock News

Amanta Healthcare Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Amanta Healthcare on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Amanta Healthcare stood at ₹0.00.
The latest P/E ratio of Amanta Healthcare as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Amanta Healthcare as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Amanta Healthcare is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amanta Healthcare is ₹184.9 ( Cr.) .

About Amanta Healthcare Ltd

Marck Biosciences Limited was originally incorporated as Marck Parenterals (India) Limited on December 1994. Subsequently, the name of the company was changed to Marck Biosciences Limited on November 2, 2005. The company’s registered office is located at 5th Floor, Heritage, Nr. Gujarat Vidhyapith, Off. Ashram Road,Ahmedabad – 380 014, Gujarat, India. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of Fluid Therapy, Injections, Eye Care and Respiratory Care. Its non therapeutic product group comprises of Medical Devices. Medical devices would predominantly be of products such as, Lens cleaning solutions, Eye & wound Irrigation, Eye wash Solution and First aid Solution, for which the company has obtained ‘CE’ mark.

Business Profile:

The company is a sterile liquid pharmaceutical company headquartered at Ahmedabad, Gujarat, India. Its scope of activities includes formulation and development, manufacturing and marketing in India and approximately 77 countries across 6 continents. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of fluid therapy, injections, eye care and respiratory care. The non therapeutic product group comprises of medical devices. medical devices would predominantly be of products such as, lens cleaning solutions, eye and wound irrigation, eye wash solution and first aid Solution, for which the company has obtained ‘CE’ mark. Its manufacturing facilities comprises of five Aseptic Blow Fill Seal (ABFS) manufacturing lines and one Aspectic Conventional Plastic Bottle Filling line. It is one of the versatile manufacturer in BFS space, wherein it offer different closure systems, such as nipple head, twist-off, leur-lock & screw types and container fill-volume ranging from 2ml to 1000 ml.

Product Segment:

  • Fluid Therapy Products
  • Formulations
  • Medical Devices

Promoter Group Companies :

  • Milcent Appliances Private Limited (MAPL)
  • American Mannequin INC

Group entities:

  • Marck Remedies Limited (MRL)
  • Mangneto Induction Pvt Limited
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.